-
1
-
-
84872967522
-
Cancer statistics, 2013
-
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11-30.
-
(2013)
CA Cancer J Clin
, vol.63
, Issue.1
, pp. 11-30
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
2
-
-
84875298116
-
Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review
-
Chen X, Liu Y, Røe OD, Qian Y, Guo R, Zhu L, et al. Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review. PLoS One. 2013;8(3):e59314.
-
(2013)
PLoS One
, vol.8
, Issue.3
, pp. e59314
-
-
Chen, X.1
Liu, Y.2
Røe, O.D.3
Qian, Y.4
Guo, R.5
Zhu, L.6
-
3
-
-
79960218807
-
Genotype-driven therapies for non-small cell lung cancer: focus on EGFR, KRAS and ALK gene abnormalities
-
Gaughan EM, Costa DB. Genotype-driven therapies for non-small cell lung cancer: focus on EGFR, KRAS and ALK gene abnormalities. Ther Adv Med Oncol. 2011;3(3):113-25.
-
(2011)
Ther Adv Med Oncol
, vol.3
, Issue.3
, pp. 113-125
-
-
Gaughan, E.M.1
Costa, D.B.2
-
4
-
-
84899153467
-
Prognostic implications of ezrin and phosphorylated ezrin expression in non-small cell lung cancer
-
Jin T, Jin J, Shang Y, Zhang S, Yu K, Piao Y, et al. Prognostic implications of ezrin and phosphorylated ezrin expression in non-small cell lung cancer. BMC Cancer. 2014;14:191.
-
(2014)
BMC Cancer
, vol.14
, pp. 191
-
-
Jin, T.1
Jin, J.2
Shang, Y.3
Zhang, S.4
Yu, K.5
Piao, Y.6
-
5
-
-
33645221836
-
Update of the NAD(P)H: quinone oxidoreductase (NQO) gene family
-
Vasilious V, Rose D, Nebert DW. Update of the NAD(P)H: quinone oxidoreductase (NQO) gene family. Hum Genomic. 2006;2(5):329-35.
-
(2006)
Hum Genomic
, vol.2
, Issue.5
, pp. 329-335
-
-
Vasilious, V.1
Rose, D.2
Nebert, D.W.3
-
6
-
-
77953204247
-
Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells
-
Buranrat B, Prawan A, Kukongviriyapan U, Kongpetch S, Kukongviriyapan V. Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells. World J Gastroenterol. 2010;16(19):2362-70.
-
(2010)
World J Gastroenterol
, vol.16
, Issue.19
, pp. 2362-2370
-
-
Buranrat, B.1
Prawan, A.2
Kukongviriyapan, U.3
Kongpetch, S.4
Kukongviriyapan, V.5
-
7
-
-
2142655894
-
NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavengar
-
Siegel D, Gustafson DL, Dehn DL, Han JY, Boonchoong P, Berliner LJ, et al. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavengar. Mol Pharmacol. 2004;65(5):1238-47.
-
(2004)
Mol Pharmacol
, vol.65
, Issue.5
, pp. 1238-1247
-
-
Siegel, D.1
Gustafson, D.L.2
Dehn, D.L.3
Han, J.Y.4
Boonchoong, P.5
Berliner, L.J.6
-
8
-
-
0030739681
-
The reduction of alpha-tocopherolquinone by human NAD(P)H: quinone oxidoreductase: the role of alpha-tocopherolhydrolquinone as a cellular antioxidant
-
Siegel D, Bolton EM, Burr JA, Liebler DC, Ross D. The reduction of alpha-tocopherolquinone by human NAD(P)H: quinone oxidoreductase: the role of alpha-tocopherolhydrolquinone as a cellular antioxidant. Mol Pharmacol. 1997;52(2):300-5.
-
(1997)
Mol Pharmacol
, vol.52
, Issue.2
, pp. 300-305
-
-
Siegel, D.1
Bolton, E.M.2
Burr, J.A.3
Liebler, D.C.4
Ross, D.5
-
9
-
-
0033801337
-
Immunodetection of NAD(P)H: quinone oxidoreductase 1 (NQO1) in human tissues
-
Siegel D, Ross D. Immunodetection of NAD(P)H: quinone oxidoreductase 1 (NQO1) in human tissues. Free RadicBiol Med. 2000;29(2-3):246-53.
-
(2000)
Free RadicBiol Med
, vol.29
, Issue.2-3
, pp. 246-253
-
-
Siegel, D.1
Ross, D.2
-
10
-
-
33744729998
-
NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancer: a meta-analysis
-
Chao C, Zhang ZF, Berthiller J, Boffetta P, Hashibe M. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(5):979-87.
-
(2006)
Cancer Epidemiol Biomarkers Prev
, vol.15
, Issue.5
, pp. 979-987
-
-
Chao, C.1
Zhang, Z.F.2
Berthiller, J.3
Boffetta, P.4
Hashibe, M.5
-
11
-
-
37549056508
-
NQO1 expression in pancreatic cancer and its potentail use as a biomarker
-
Awadallah NS, Dehn D, Shah RJ, Russell Nash S, Chen YK, Ross D, et al. NQO1 expression in pancreatic cancer and its potentail use as a biomarker. ApplImmunohistochem Mol Morphol. 2008;16(1):24-31.
-
(2008)
ApplImmunohistochem Mol Morphol
, vol.16
, Issue.1
, pp. 24-31
-
-
Awadallah, N.S.1
Dehn, D.2
Shah, R.J.3
Russell Nash, S.4
Chen, Y.K.5
Ross, D.6
-
12
-
-
84874085253
-
NQO1 expression correlates with cholangiocarcinoma prognosis
-
Buranrat B, Chau-in S, Prawan A, Puapaoroj A, Zeekpudsa P, Kukongviriyapan V. NQO1 expression correlates with cholangiocarcinoma prognosis. Asian Pac J Cancer Pre. 2012;13(Suppl):131-6.
-
(2012)
Asian Pac J Cancer Pre
, vol.13
, pp. 131-136
-
-
Buranrat, B.1
Chau-in, S.2
Prawan, A.3
Puapaoroj, A.4
Zeekpudsa, P.5
Kukongviriyapan, V.6
-
13
-
-
77952671578
-
The NAD(P)H:Quinone Oxidoreductase 1 inducescell cycle progression and proliferation of melanoma cells
-
Garate M, Wani AA, Li G. The NAD(P)H:Quinone Oxidoreductase 1 inducescell cycle progression and proliferation of melanoma cells. Free RadicBiolMed. 2010;48(12):1601-9.
-
(2010)
Free RadicBiolMed
, vol.48
, Issue.12
, pp. 1601-1609
-
-
Garate, M.1
Wani, A.A.2
Li, G.3
-
15
-
-
5444240961
-
Contribution of NAD(P)H: quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors
-
Nioi P, Hayes JD. Contribution of NAD(P)H: quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutat Res. 2004;555(1-2):149-71.
-
(2004)
Mutat Res
, vol.555
, Issue.1-2
, pp. 149-171
-
-
Nioi, P.1
Hayes, J.D.2
-
16
-
-
50849144372
-
Time-dependent acetylsalicylic acid effects on liver CYP1A and antioxidant enzymes in a rat model of 7,12-dimethylbenzanthracene(DMBA)-induced mammary carcinogenesis
-
Girolami F, Abbadessa G, Racca S, Spaccamiglio A, Piccione F, Dacasto M, et al. Time-dependent acetylsalicylic acid effects on liver CYP1A and antioxidant enzymes in a rat model of 7,12-dimethylbenzanthracene(DMBA)-induced mammary carcinogenesis. Toxicol Lett. 2008;181(2):87-92.
-
(2008)
Toxicol Lett
, vol.181
, Issue.2
, pp. 87-92
-
-
Girolami, F.1
Abbadessa, G.2
Racca, S.3
Spaccamiglio, A.4
Piccione, F.5
Dacasto, M.6
-
17
-
-
84874219564
-
C609Tpolymorphism of NADPH Quinone Oxidoreductase 1 Correlates clinicalhematological toxicities in lung cancer patients treated with Amrubicin
-
Nagata M, Kimura T, Suzumura T, Kira Y, Nakai T, Umekawa K, et al. C609Tpolymorphism of NADPH Quinone Oxidoreductase 1 Correlates clinicalhematological toxicities in lung cancer patients treated with Amrubicin. Clin Med Insights Oncol. 2013;7:31-9.
-
(2013)
Clin Med Insights Oncol
, vol.7
, pp. 31-39
-
-
Nagata, M.1
Kimura, T.2
Suzumura, T.3
Kira, Y.4
Nakai, T.5
Umekawa, K.6
-
18
-
-
84865131503
-
Role of NQO1 609C > T and NQO2-3423G > A gene polymorphisms in esophageal cancer risk in Kashmir valley andmeta analysis
-
Malik MA, Zargar SA, Mittal B. Role of NQO1 609C > T and NQO2-3423G > A gene polymorphisms in esophageal cancer risk in Kashmir valley andmeta analysis. Mol Biol Rep. 2012;39(9):9095-104.
-
(2012)
Mol Biol Rep
, vol.39
, Issue.9
, pp. 9095-9104
-
-
Malik, M.A.1
Zargar, S.A.2
Mittal, B.3
-
19
-
-
46249125252
-
NAD(P)H: quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer
-
Fagerholm R, Hofstetter B, Tommiska J, Aaltonen K, Vrtel R, Syrjäkoski K, et al. NAD(P)H: quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer. Nat Genet. 2008;40(7):844-53.
-
(2008)
Nat Genet
, vol.40
, Issue.7
, pp. 844-853
-
-
Fagerholm, R.1
Hofstetter, B.2
Tommiska, J.3
Aaltonen, K.4
Vrtel, R.5
Syrjäkoski, K.6
-
20
-
-
0035969989
-
Regulation of p53 stability and p53-dependent apoptosis by NADH quinoneoxidoreductase 1
-
Asher G, Lotem J, Cohen B, Sachs L, Shaul Y. Regulation of p53 stability and p53-dependent apoptosis by NADH quinoneoxidoreductase 1. Proc NatlAcadSci U S A. 2001;98(3):1188-93.
-
(2001)
Proc NatlAcadSci U S A
, vol.98
, Issue.3
, pp. 1188-1193
-
-
Asher, G.1
Lotem, J.2
Cohen, B.3
Sachs, L.4
Shaul, Y.5
-
21
-
-
14644446056
-
20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1
-
Asher G, Bercovich Z, Tsvetkov P, Shaul Y, Kahana C. 20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1. Mol Cell. 2005;17(5):645-55.
-
(2005)
Mol Cell
, vol.17
, Issue.5
, pp. 645-655
-
-
Asher, G.1
Bercovich, Z.2
Tsvetkov, P.3
Shaul, Y.4
Kahana, C.5
-
22
-
-
84893196764
-
Clinical implications of high NQO1 expression inbreast cancers
-
Yang Y, Zhang Y, Wu Q, Cui X, Lin Z, Liu S, et al. Clinical implications of high NQO1 expression inbreast cancers. J Exp Clin Cancer Res. 2014;33:14.
-
(2014)
J Exp Clin Cancer Res
, vol.33
, pp. 14
-
-
Yang, Y.1
Zhang, Y.2
Wu, Q.3
Cui, X.4
Lin, Z.5
Liu, S.6
-
23
-
-
84902551532
-
NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix
-
Ma Y, Kong J, Yan G, Ren X, Jin D, Jin T, et al. NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix. BMC Cancer. 2014;14:414.
-
(2014)
BMC Cancer
, vol.14
, pp. 414
-
-
Ma, Y.1
Kong, J.2
Yan, G.3
Ren, X.4
Jin, D.5
Jin, T.6
-
24
-
-
84894098464
-
Significance of NQO1overexpression for prognostic evaluation of gastric adenocarcinoma
-
Lin L, Qin Y, Jin T, Liu S, Zhang S, Shen X, et al. Significance of NQO1overexpression for prognostic evaluation of gastric adenocarcinoma. Exp Mol Pathol. 2014;96(2):200-5.
-
(2014)
Exp Mol Pathol
, vol.96
, Issue.2
, pp. 200-205
-
-
Lin, L.1
Qin, Y.2
Jin, T.3
Liu, S.4
Zhang, S.5
Shen, X.6
-
25
-
-
37549056508
-
NQO1 expression in pancreatic cancer and its potential use as a biomarker
-
Awadallah NS, Dehn D, Shah RJ, Russell Nash S, Chen YK, Ross D, et al. NQO1 expression in pancreatic cancer and its potential use as a biomarker. Appl Immunohistochem Mol Morphol. 2008;16(1):24-31.
-
(2008)
Appl Immunohistochem Mol Morphol
, vol.16
, Issue.1
, pp. 24-31
-
-
Awadallah, N.S.1
Dehn, D.2
Shah, R.J.3
Russell Nash, S.4
Chen, Y.K.5
Ross, D.6
-
26
-
-
33644851998
-
Increased levels of NAD(P)H: quinoneoxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: A potential biomarker of early damage in the pancreas
-
Lyn-Cook BD, Yan-Sanders Y, Moore S, Taylor S, Word B, Hammons GJ. Increased levels of NAD(P)H: quinoneoxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: A potential biomarker of early damage in the pancreas. Cell Biol Toxicol. 2006;22(2):73-80.
-
(2006)
Cell Biol Toxicol
, vol.22
, Issue.2
, pp. 73-80
-
-
Lyn-Cook, B.D.1
Yan-Sanders, Y.2
Moore, S.3
Taylor, S.4
Word, B.5
Hammons, G.J.6
-
27
-
-
0026700546
-
Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cl
-
Malkinson AM, Siegel D, Forrest GL, Gazdar AF, Oie HK, Chan DC, et al. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cl. Cancer Res. 1992;52(17):4752-7.
-
(1992)
Cancer Res
, vol.52
, Issue.17
, pp. 4752-4757
-
-
Malkinson, A.M.1
Siegel, D.2
Forrest, G.L.3
Gazdar, A.F.4
Oie, H.K.5
Chan, D.C.6
-
28
-
-
0029073531
-
Identification of an NAD(P)H: quinone oxidoreductase polymorphism and its association with lung cancer and smoking
-
Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH. Identification of an NAD(P)H: quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics. 1995;5(4):199-206.
-
(1995)
Pharmacogenetics
, vol.5
, Issue.4
, pp. 199-206
-
-
Rosvold, E.A.1
McGlynn, K.A.2
Lustbader, E.D.3
Buetow, K.H.4
-
30
-
-
0031791376
-
Immunological quantitation of DT-diaphorase in carcinoma cell lines and clinical colon cancers: advanced tumors express greater levels of DT-diaphorase
-
Mikami K, Naito M, Ishiguro T, Yano H, Tomida A, Yamada T, et al. Immunological quantitation of DT-diaphorase in carcinoma cell lines and clinical colon cancers: advanced tumors express greater levels of DT-diaphorase. Jpn J Cancer Res. 1998;89(9):910-5.
-
(1998)
Jpn J Cancer Res
, vol.89
, Issue.9
, pp. 910-915
-
-
Mikami, K.1
Naito, M.2
Ishiguro, T.3
Yano, H.4
Tomida, A.5
Yamada, T.6
-
31
-
-
84912116456
-
Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer
-
Kim HC, Song JS, Lee JC, Lee DH, Kim SW, Lee JS, et al. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer. Int J Clin Exp Pathol. 2014;7(10):6743-51.
-
(2014)
Int J Clin Exp Pathol
, vol.7
, Issue.10
, pp. 6743-6751
-
-
Kim, H.C.1
Song, J.S.2
Lee, J.C.3
Lee, D.H.4
Kim, S.W.5
Lee, J.S.6
-
32
-
-
0028645493
-
Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase
-
Workman P. Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase. Oncol Res. 1994;6(10-11):461-75.
-
(1994)
Oncol Res
, vol.6
, Issue.10-11
, pp. 461-475
-
-
Workman, P.1
-
33
-
-
84901023217
-
β-Lapachoneindcuces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells
-
Park EJ, Min KJ, Lee TJ, Yoo YH, Kim YS, Kwon TK. β-Lapachoneindcuces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells. Cell Death Dis. 2014;5:e1230.
-
(2014)
Cell Death Dis
, vol.5
, pp. e1230
-
-
Park, E.J.1
Min, K.J.2
Lee, T.J.3
Yoo, Y.H.4
Kim, Y.S.5
Kwon, T.K.6
-
34
-
-
84895515192
-
Sulindac Compounds Facilitate the Cytotoxicity of β-Lapachone by Up-Regulation of NAD(P)H Quinone Oxidoreductase in Human Lung Cancer Cells
-
Kung H, Weng T, Liu Y, Lu K, Chau Y. Sulindac Compounds Facilitate the Cytotoxicity of β-Lapachone by Up-Regulation of NAD(P)H Quinone Oxidoreductase in Human Lung Cancer Cells. PLoS One. 2014;9(2):e88122.
-
(2014)
PLoS One
, vol.9
, Issue.2
, pp. e88122
-
-
Kung, H.1
Weng, T.2
Liu, Y.3
Lu, K.4
Chau, Y.5
-
35
-
-
84862566809
-
An NQO1 Substrate with Potent Antitumor Activity That Selectively Kills by PARP1-Induced Programmed Necrosis
-
Huang X, Dong Y, Bey E. An NQO1 Substrate with Potent Antitumor Activity That Selectively Kills by PARP1-Induced Programmed Necrosis. Cancer Res. 2012;72(12):3038-47.
-
(2012)
Cancer Res
, vol.72
, Issue.12
, pp. 3038-3047
-
-
Huang, X.1
Dong, Y.2
Bey, E.3
|